Hong Kong Develops AI Tool for Enhanced Breast Cancer Diagnosis

Researchers at the Hong Kong University of Science and Technology have introduced MOME, an innovative AI model for non-invasive breast cancer diagnosis. This model, trained on China’s largest multiparametric MRI breast cancer dataset, matches the accuracy of expert radiologists and is currently being tested in over ten hospitals, including Shenzhen People’s Hospital and Yunnan Cancer Center. Preliminary findings indicate that MOME is particularly effective at predicting responses to pre-surgical chemotherapy. This advancement underscores the burgeoning capabilities in medical technology within the region and has the potential to revolutionize breast cancer diagnostic approaches across Asia. The success of MOME may also lead to the development of similar AI models in oncology, signaling a shift toward AI integration in medical diagnostics.

Source link